Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial

RATIONALE: Aside from blood pressure lowering, treatment options for intracerebral haemorrhage remain limited and a proportion of patients will undergo early haematoma expansion with resultant significant morbidity and mortality. Tranexamic acid (TXA), an anti-fibrinolytic drug, has been shown to si...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Trials
Päätekijät: Flaherty, Katie, Bath, Philip M., Dineen, Robert, Law, Zhe, Scutt, Polly, Pocock, Stuart, Sprigg, Nikola
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Update
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738041/
https://ncbi.nlm.nih.gov/pubmed/29262841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-2341-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia